Author

Maria T. Abreu 1

1 University of Miami, Miller School of Medicine, Miami, United States

Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Yiying Zhou, Ilia Tikhonov, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Colleen W.

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen J. Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

David Rowbotham, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, Ramesh P. Arasaradnam, Waqqas Afif, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

Impact of Response and Inflammatory Burden at Start of Maintenance Therapy on Clinical Efficacy of Ustekinumab Dosing Regimen in UC: Week 44 Results from UNIFI

Remo Panaccione, Laurent Peyrin-Biroulet, Silvio Danese, Colleen W. Marano, Christopher D. O'Brien, Philippe Szapary, Hongyan Zhang, Jewel Johanns, Rupert W Leong, Ramesh P. Arasaradnam, David Rowbotham, Maria T. Abreu, Bruce E. Sands

Implementation of disease monitoring and its challenges in practice: An integrated view

Maria T. Abreu

Inflammatory bowel disease

Maria T. Abreu

Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients with Ulcerative Colitis: Results from the UNIFI Induction and Maintenance Studies

Joseph Adedokun, Zhenhua Xu, Colleen W. Marano, Christopher O’Brien, Philippe Szapary, Hongyan Zhang, Jewel Johanns, Rupert W Leong, Tadakazu Hisamatsu, Gert Van Assche, Silvio Danese, Maria T. Abreu, Bruce E. Sands, William Sandborn

PHARMACOKINETICS AND IMMUNOGENICITY OF MAINTENANCE THERAPY WITH USTEKINUMAB: 2-YEAR RESULTS FROM THE UNIFI LONG-TERM EXTENSION STUDY

Omoniyi J. Adedokun, Remo Panaccione, Tadakazu Hisamatsu, Maria T. Abreu, Rupert W.L. Leong, David Rowbotham, Colleen W. Marano, Yiying Zhou, Hongyan Zhang, Silvio Danese, Waqqas Afif, Laurent Peyrin-Biroulet, William Sandborn, Bruce E. Sands

REDUCTIONS IN CORTICOSTEROID USE IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE TREATED WITH VEDOLIZUMAB

Bruce E. Sands, Stephen B Hanauer, Jean-Frederic Colombel, Silvio Danese, Terry Ponich, Serap Sankoh, Michael Smyth, Brihad Abhyankar, Irving Fox, Brian G. Feagan, Maria T. Abreu

SAFETY AND EFFICACY OF USTEKINUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 UNIFI STUDY

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen W. Marano

Item 11 - 20 / 28
1
2
3